ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1502

The Systemic Lupus International Collaborating Clinics (SLICC) Frailty Index (SLICC-FI) Predicts Hospitalizations. Data from the Almenara Lupus Cohort

Manuel Ugarte-Gil1, RV, Gamboa-Cardenas2, Victor Pimentel-Quiroz3, Cristina Reategui4, Claudia Elera Fitzcarrald5, Cesar Pastor-Asurza6, Zoila Rodriguez-Bellido6, Risto Perich-Campos6 and Graciela Alarcon7, 1Universidad Cientifica del Sur, Lima, Lima, Peru, 2Universidad Científica del Sur, Lima, Lima, Peru, 3Universidad Científica del Sur/Hospital Nacional Guillermo Almenara Irigoyen, Magdalena del Mar, Peru, 4Servicio de Reumatología. Hospital Nacional Guillermo Almenara Irigoyen, EsSalud/Grupo Peruano de Estudio de Enfermedades Autoinmunes Sistémicas, Universidad Científica del Sur, Lima, Lima, Peru, 5Hospital Nacional Guillermo Almenara Irigoyen/Universidad San Ignacio de Loyola, Lima, Peru, 6Hospital Nacional Guillermo Almenara Irigoyen, Lima, Lima, Peru, 7The University of Alabama at Birmingham, Oakland, CA

Meeting: ACR Convergence 2024

Keywords: Outcome measures, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: SLE – Diagnosis, Manifestations, & Outcomes Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Frailty, measured with the SLICC-FI, has been reported as a predictor of damage in several cohorts. The aim of this study is to evaluate the SLICC-FI as a predictor of hospitalization in systemic lupus erythematosus (SLE) patients.

Methods: Patients from a single-center prevalent cohort were included. The SLICC-FI was measured at baseline. Hospitalizations were reported during the first two years after the baseline visit as their number as well as their duration.
Univariable and multivariable negative binomial regressions were performed to determine the association between the baseline SLICC-FI (per 0.05 increase) and hospitalizations during follow-up (number and length), adjusted for sex, age at diagnosis, socioeconomic status, educational level, disease duration, SLE Disease Activity Index 2000 (SLEDAI-2K), SLICC damage index (SDI), prednisone daily dose, antimalarial and immunosuppressive drug use at baseline.

Results: Of the 302 patients included 280 (92.7%) were female, with mean (SD) age at diagnosis of 34.6 (7.2) years. At baseline, the mean (SD) disease duration was 7.2 (6.4) years, and the mean (SD) SLICC-FI was 0.21 (0.05). The mean number of hospitalizations per patient was 0.5 (1.6) and the mean number of days hospitalized during the two-year period per patient was 5.3 (16.8) days; 58 (17.9%) of the patients were hospitalized at least once during the follow-up. The SLICC-FI predicted a higher probability of hospitalizations as well as with a higher number of hospitalizations; these data are depicted in table 1.

Conclusion: The SLICC-FI predicts hospitalizations in SLE patients, independently of other well-known risk factors of hospitalizations. Further studies are needed to determine strategies to improve frailty in SLE patients.

Supporting image 1


Disclosures: M. Ugarte-Gil: AstraZeneca, 1, 6, Ferrer, 1, GlaxoSmithKlein(GSK), 6, Janssen, 5, Tecnofarma, 2, 6, 12, Travel Support; R. Gamboa-Cardenas: None; V. Pimentel-Quiroz: None; C. Reategui: None; C. Elera Fitzcarrald: None; C. Pastor-Asurza: None; Z. Rodriguez-Bellido: None; R. Perich-Campos: None; G. Alarcon: None.

To cite this abstract in AMA style:

Ugarte-Gil M, Gamboa-Cardenas R, Pimentel-Quiroz V, Reategui C, Elera Fitzcarrald C, Pastor-Asurza C, Rodriguez-Bellido Z, Perich-Campos R, Alarcon G. The Systemic Lupus International Collaborating Clinics (SLICC) Frailty Index (SLICC-FI) Predicts Hospitalizations. Data from the Almenara Lupus Cohort [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/the-systemic-lupus-international-collaborating-clinics-slicc-frailty-index-slicc-fi-predicts-hospitalizations-data-from-the-almenara-lupus-cohort/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-systemic-lupus-international-collaborating-clinics-slicc-frailty-index-slicc-fi-predicts-hospitalizations-data-from-the-almenara-lupus-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology